IXCHIQ
2025/CHU/12
Approved mab active
Quick answer
IXCHIQ for Chikungunya Virus Infection is a Approved program (mab) at Ars Pharmaceuticals Irl Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ars Pharmaceuticals Irl Limited
- Indication
- Chikungunya Virus Infection
- Phase
- Approved
- Modality
- mab
- Status
- active